Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emulgel is a topical formulation designed for the concomitant treatment of atopic dermatitis (AD). It combines the properties of emulsions and gels, offering easy spreadability, emollience, and enhanced skin penetration. The formulation contains a blend of active ingredients including hyaluronic acid, glycerol, Calendula officinalis extract, Aloe vera extract, polyphenols from grape seed oil, and epidermal growth factor (EGF). This combination aims to improve skin barrier function, reduce inflammation, promote hydration, and support skin repair, thereby alleviating symptoms of AD. The EGF component is stabilized using a patented method to ensure its efficacy within the emulsion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on emulgel.